Andrew Goodall
Nessuna posizione attualmente
Patrimonio netto: 1 M $ in data 31/05/2024
Profilo
Andrew Ernest Goodall served as a Non-Executive Director at Memphasys Ltd.
from 2012 to 2023.
He also held the same position at PrIME Biologics Pte Ltd.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
MEMPHASYS LTD
13.17% | 29/11/2023 | 180 149 529 ( 13.17% ) | 1 M $ | 31/05/2024 |
Precedenti posizioni note di Andrew Goodall
| Società | Posizione | Fine |
|---|---|---|
| MEMPHASYS | Direttore/Membro del Consiglio | 30/11/2023 |
PrIME Biologics Pte Ltd.
 PrIME Biologics Pte Ltd. BiotechnologyHealth Technology PrIME Biologics Pte Ltd. develops disposable therapeutic plasma manufacturing process. Its process doubles product yields while increasing product safety and removing viruses, bacteria, endotoxins, and prions. The firm’s process reduces the time it takes to produce multiple plasma products from days to hours. The company is headquartered in Singapore. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MEMPHASYS | Health Technology |
| Aziende private | 1 |
|---|---|
PrIME Biologics Pte Ltd.
PrIME Biologics Pte Ltd. BiotechnologyHealth Technology PrIME Biologics Pte Ltd. develops disposable therapeutic plasma manufacturing process. Its process doubles product yields while increasing product safety and removing viruses, bacteria, endotoxins, and prions. The firm’s process reduces the time it takes to produce multiple plasma products from days to hours. The company is headquartered in Singapore. | Health Technology |
- Borsa valori
- Insiders
- Andrew Goodall
